US Patent 8840885 Methods for treating chronic lymphocytic leukemia
Patent 8840885 was granted and assigned to Alexion Pharmaceuticals, Inc. on September, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
John McWhirter0
Katherine S. Bowdish0
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08840885 Methods for treating chronic lymphocytic leukemia US Patent 8840885 Methods for treating chronic lymphocytic leukemia
Infobox
Patent Number
088408850
Patent Number
88408850
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
088408850
Date of Patent
September 23, 2014
0Patent Application Number
130290210
Date Filed
February 16, 2011
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 26 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08840885 Methods for treating chronic lymphocytic leukemia
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08840885
Date of patent
September 23, 2014
Patent application number
13029021
Date Filed
February 16, 2011
Patent primary examiner
Find more entities like US Patent 8840885 Methods for treating chronic lymphocytic leukemia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
